A B Scott|J A De Groot - JoVE Visualize

Showing results (91-100 of 106) with videos related to

Pageof 11

Sort By:

Diabetes Care|July 10, 2020

Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE TrialHertzel C Gerstein, Ruth L Coleman, Charles A B Scott, et al.

Journal of Clinical Neuro-Ophthalmology|March 1, 1983

Clinical and subclinical oculomotor findings in the Eaton-Lambert syndromeM P Cruciger, B Brown, E H Denys, et al.

European Journal of Pediatrics|October 12, 2013

Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoinC Breen, F J White, C A B Scott, et al.

Diabetes Research and Clinical Practice|October 9, 2020

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trialMalgorzata Wamil, John J V McMurray, Charles A B Scott, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 2006

Lysosomal storage diseases in non-immune hydrops fetalis pregnanciesAngelique J A Kooper, Pim M W Janssens, Akosua N J A de Groot, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021

First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 ProbodyLaura Kist de Ruijter, Jahlisa S Hooiveld-Noeken, Danique Giesen, et al.

Annals of Surgical Oncology|August 27, 2014

Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancerC Bisschop, J J J Tjalma, G A P Hospers, et al.

Diabetes, Obesity & Metabolism|April 24, 2026

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY AnalysisJoão Sérgio Neves, Ana Rita Leite, Francisco Vasques-Nóvoa, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 5, 2021

89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancerI C Kok, J S Hooiveld, P P van de Donk, et al.

Nature Medicine|December 5, 2022

Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trialLaura Kist de Ruijter, Pim P van de Donk, Jahlisa S Hooiveld-Noeken, et al.

Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:

Pageof 11

Diabetes Care|July 10, 2020

Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE TrialHertzel C Gerstein, Ruth L Coleman, Charles A B Scott, et al.

Journal of Clinical Neuro-Ophthalmology|March 1, 1983

Clinical and subclinical oculomotor findings in the Eaton-Lambert syndromeM P Cruciger, B Brown, E H Denys, et al.

European Journal of Pediatrics|October 12, 2013

Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoinC Breen, F J White, C A B Scott, et al.

Diabetes Research and Clinical Practice|October 9, 2020

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trialMalgorzata Wamil, John J V McMurray, Charles A B Scott, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|May 6, 2006

Lysosomal storage diseases in non-immune hydrops fetalis pregnanciesAngelique J A Kooper, Pim M W Janssens, Akosua N J A de Groot, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021

First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 ProbodyLaura Kist de Ruijter, Jahlisa S Hooiveld-Noeken, Danique Giesen, et al.

Annals of Surgical Oncology|August 27, 2014

Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancerC Bisschop, J J J Tjalma, G A P Hospers, et al.

Diabetes, Obesity & Metabolism|April 24, 2026

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY AnalysisJoão Sérgio Neves, Ana Rita Leite, Francisco Vasques-Nóvoa, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 5, 2021

89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancerI C Kok, J S Hooiveld, P P van de Donk, et al.

Nature Medicine|December 5, 2022

Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trialLaura Kist de Ruijter, Pim P van de Donk, Jahlisa S Hooiveld-Noeken, et al.

Pageof 11